NEW YORK ( TheStreet) -- "There are only 35 trading days left in the year," Jim Cramer told the viewers of his "Mad Money" TV show Monday, "and there are no data points left to derail the bulls." Cramer said investors need to consider where we are on the calendar. The markets have just entered a data void until the end of the year, he said. The companies have all spoken, most with upside surprises. The Federal Reserve has spoken, saying it's not raising rates anytime soon. The hedge funds are done liquidating until the end of the year. There is no major economic data coming out. What does it all mean? Cramer said it means there is nothing for the bears to latch onto, and nothing to stop the bulls.
Valuating AssetsThere's a crisis of credibility on Wall Street, Cramer said, and that's good news for the financial audit firm of Duff & Phelps ( DUF). He said with increased government intervention into the private sector and no one having a clue have financial instruments are really worth, Duff & Phelps is the perfect "stock for the moment." Cramer said Duff's specialty is valuation and advisory services, which hedge funds, mutual funds and companies use when they're buying or selling complex assets or businesses. He said in a typical transaction, a seller might use "mark-to-model" accounting, and value their assets too high, while the buyer would likely use "mark-to-market" accounts, which often values assets too low. Duff & Phelps would act as the referee, and provide both parties with a fair valuation. Cramer said with the pickup in mergers and acquisitions, and on the flip side, a pickup in bankruptcies and spin offs, Duff's services are in demand. The stellar company is used by 12 out of the top 25 largest global hedge funds and 13 of the top 25 largest private equity funds, he said. Duff is currently growing earnings at 20% a year, yet trades at just 15 times its earnings. That's too low said Cramer, who is willing to pay twice the growth rate for a stock. He said the stock was stalled ahead of a planned secondary offering, but with that overhang now lifted, Duff & Phelps should be ready to ride the wave of distrust on Wall Street.
Priced Too HighIn the "Know Your IPO" segment, Cramer told viewers that it doesn't matter how great a company's IPO is, if it's priced too high. He said this appears to be the case with Dollar General, the country's largest dollar store chain, which is set to come public this week under the ticker "DG" between $21 and $23 a share. Cramer said the Dollar General IPO is being underwritten by Goldman Sachs, a firm which hurt investors with the overpriced IPO of Dole Foods ( DOLE) last month. Dole came public at $12.50 a share, only to immediately trade lower. The stock is currently trading at only $11.96 a share. Cramer said there's no question that Dollar General is the best dollar-store operator out there, but the IPO deal is making him nervous. First, he said that insiders are cashing out with nearly one third of the offering. Second, the company will still have a mountain of debt, $3.7 billion worth that it must still contend with. Lastly, he said the company will still be controlled by the company's current investors, which leaves little recourse for shareholders. According to Cramer, Dollar General should price at a premium that should not exceed $19 a share. At $21 to $23 a share, Cramer said this deal just lines the pockets of the insiders and the bankers, and investors need to stay away.
Mad MailCramer followed up on some recent "Lightning Round" stocks that stumped him. He said that American Capital Agency ( AGNC) is too risky if the Federal Reserve begins raising rates and he'd steer clear. Cramer said that Fuqi ( FUQI), a Chinese jewelry maker, may be an interesting way to play the rise of the middle class in China. He also said that Genomic Health ( GHDX), a cancer diagnostics maker, is a very speculative way to play the fight against cancer. Cramer told a final viewer that Warren Buffet is a great man, and he'd be a buyer of Berkshire Hathoway ( BRK-B), especially given the coming 50:1 stock split, which will make shares more accessible to smaller investors.
Lightning RoundCramer was bullish on American Express ( AXP - Get Report), Targacept ( TRGT), Allos Therapeutics ( ALTH) and Becton Dickinson ( BDX - Get Report). He was bearish on Regeneron Pharmaceuticals Inc ( REGN - Get Report), Motorola ( MOT), Alcon ( ACL), MetroPCS Communications ( PCS), Frontline ( FRO - Get Report) and Beckman Coulter Inc ( BEC). To watch replays of Cramer's video segments, visit the